Very late disease relapse in patient with B-common acute lymphoblastic leukemia treated with allogeneic stem cell transplantation: does clonal evolution play a role?
- Resource Type
- Case Study
- Authors
- Płotka, Anna; Przybyłowicz-Chalecka, Anna; Korolczuk, Maria; Kanduła, Zuzanna; Kiernicka-Parulska, Jolanta; Mierzwa, Anna; Jarmuż-Szymczak, Małgorzata; Gil, Lidia; Lewandowski, Krzysztof
- Source
- Acta Haematologica Polonica; 2023, Vol. 54 Issue 3, p187-190, 4p
- Subject
- LYMPHOBLASTIC leukemia
STEM cell transplantation
ACUTE leukemia
DISEASE relapse
MEDICAL ethics
- Language
- ISSN
- 00015814
The article presents a case report of a patient with B-cell acute lymphoblastic leukemia (ALL) who experienced a relapse 13 years after treatment with chemotherapy and an allogeneic hematopoietic stem cell transplantation (allo-HSCT). The patient was initially diagnosed with B-common ALL in 2008 and achieved complete remission (CR) after treatment. He underwent allo-HSCT in 2009 and remained in remission for 13 years.